Royalty Pharma

Agios cashes in on cancer drug again with $905M Royalty Pharma deal
BioPharma Dive
Tue, 05/28/24 - 10:33 pm
Agios Pharma
Royalty Pharma
brain cancer
Servier
vorasidenib
Investors say 'no bueno' as Cytokinetics stymies M&A prospects with complex Royalty deal
Fierce Biotech
Thu, 05/23/24 - 11:04 am
Cytokinetics
Royalty Pharma
aficamten
Royalty Pharma pays startup $525M for stake in Sanofi MS drug
BioPharma Dive
Thu, 05/9/24 - 07:13 pm
Sanofi
Royalty Pharma
MS
ImmuNext
frexalimab
5 of the best paid biopharma CEOs
PharmaVoice
Mon, 11/13/23 - 10:10 am
Pharma CEOs
executive compensation
Sarepta Therapeutics
Royalty Pharma
Seagen
Zentalis
Pfizer
PTC to sell spinal muscular atrophy drug royalties for $1B
BioPharma Dive
Thu, 10/19/23 - 11:34 am
PTC Therapeutics
spinal muscular atrophy
Evrysdi
Royalty Pharma
Royalty Pharma to Pay Potential $500M for Royalties on Ferring’s Gene Therapy
BioSpace
Thu, 08/24/23 - 08:34 pm
Ferring Pharmaceuticals
Royalty Pharma
gene therapy
bladder cancer
Biopharma Companies with the Biggest CEO-Employee Pay Gaps
BioSpace
Thu, 06/15/23 - 09:58 am
Pharma CEOs
executive compensation
Sarepta Therapeutics
Pfizer
Bausch + Lomb
Amneal Pharmaceuticals
Thermo Fisher
IQVIA
McKesson
Royalty Pharma
Charles Rivers Laboratories
Seagen
Royalty Pharma hands off $100M upfront for PureTech royalty on Karuna's schizophrenia hopeful
Endpoints
Thu, 03/23/23 - 11:49 am
Royalty Pharma
Karuna Therapeutics
KarXT
schizophrenia
PureTech
Royalty Pharma nabs $475M milestone from Pfizer upon migraine nasal spray OK
Endpoints
Thu, 03/16/23 - 09:46 am
Pfizer
migraines
Royalty Pharma
Biohaven
zavegepant
Royalty Pharma bets Merck's schizophrenia drug can go where Pfizer, Takeda and Lundbeck's couldn’t
Endpoints
Wed, 10/12/22 - 10:55 am
Merck
Royalty Pharma
schizophrenia
MK-8189
Unpacking Royalty Pharma
EP Vantage
Mon, 07/18/22 - 10:24 am
Royalty Pharma
Ultragenyx
Theravance gets a fresh start
EP Vantage
Thu, 07/14/22 - 10:50 am
Theravance
GSK
Trelegy Ellipta
Royalty Pharma
BioCryst gets massive cash infusion to the tune of $350M, thanks to old and new investors
Endpoints
Mon, 11/22/21 - 10:12 pm
Biocryst
Royalty Pharma
BCX9930
GlaxoSmithKline offloads royalty rights for 2 cancer drugs in $342M windfall it will use to finance consumer spinoff
Endpoints
Thu, 04/1/21 - 11:36 pm
GSK
Cabometyx
Cometriq
Royalty Pharma
Biohaven adds nearly $1B in Nurtec deals with Royalty Pharma, Sixth Street
Endpoints
Fri, 08/7/20 - 11:05 am
Biohaven
Nurtec
Royalty Pharma
Sixth Street
What pandemic? Biotech floats break records
EP Vantage
Wed, 07/8/20 - 10:37 am
biotech
IPOs
ADC Therapeutics
Akouos
Applied Molecular Transport
Avidity Biosciences
Ayala Pharmaceuticals
Forma Therapeutics
Fusion Pharmaceuticals
Generation Bio
Hyloris Pharmaceuticals
Lantern Pharma
ORIC Pharmaceuticals
Pliant Therapeutics
PolyPid
Repare Therapeutics
Royalty Pharma
SutroVax
Meet the Pharma Company That Just Had a Bigger IPO Than Moderna's
Motley Fool
Tue, 06/23/20 - 11:07 am
IPOs
Moderna Therapeutics
Royalty Pharma
The biotech IPOs keep coming at chart-topping levels — with no slowdown in sight
Endpoints
Fri, 06/19/20 - 11:27 am
biotech
IPOs
Repare Therapeutics
Forma Therapeutics
Avidity Biosciences
Vaxcyte
SK Biopharmaceuticals
Generation Bio
Royalty Pharma
Royalty Pharma scores $2.2B IPO — the biggest of the year
Endpoints
Tue, 06/16/20 - 10:44 am
Royalty Pharma
IPOs
NASDAQ
Royalty Pharma plans largest IPO of the year so far
Pharmaforum
Wed, 06/10/20 - 10:46 am
Royalty Pharma
IPOs
NASDAQ

Pages